Global Clinical Decision Support System Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$3,250$7,500

Global Clinical Decision Support System Market Outlook 2019-2030

Clear

Description

Global Clinical Decision Support System Market by Type (Therapeutic and Diagnostic); By Component (Software, Hardware and Services); By Mode of Delivery (On-Premise and Cloud); by Product Outlook (Standalone and Integrated); By Application (Drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support and Others); By Region (North America, Asia-pacific, Europe, Latin America and Middle-East and Africa)- Analysis of market share, size & trends for 2016-19 and forecasts to 2030.
Product Overview
A Clinical Decision Support System is intended to optimize health care through tailored clinical expertise, patient data, and other medical information. A modern Clinical Decision Support System consists of a program aimed to efficiently assist in the formation of clinical decisions, balancing the particular patient’s traits with computer-based medical expertise. In other words, it assists clinicians and practitioners in decision making.
Market Highlights
Global Clinical Decision Support System Market is anticipated to exceed USD 1,514.55 million by 2030 from USD 877.73 million in 2019 at a CAGR of 9.34% throughout the forecast period, i.e., 2020-30. The Global Clinical Decision Support System Market is estimated to grow on the back of the following reasons. The major factor driving the Global Clinical Decision Support System market is the increasing old-age population.
Global Clinical Decision Support System Market: Segments
Therapeutic segment to contribute maximum share during the forecast period, i.e., 2020-2030
Global clinical decision support system market by type is segmented into therapeutic and diagnostic. The therapeutic segment contributed the maximum share of the market in 2019 and is anticipated to continue capturing the largest share during forecast period owing to the large-scale implementation by clinicians and caretakers.
Global Clinical Decision Support System Market: Market Dynamics
Drivers:
Increasing Collaborations between Research institutes & CDSS companies will augment the growth of the market
Collaborations between medical research organizations and organizations providing clinical decision support result in increased investments. This funding allows CDSS companies and medical research organizations to invest in new technical approaches and to collaborate.
Restraints:
Resistance to validate mobile-based clinical decision support system
The involvement of players in healthcare IT approaches like mobile CDSS is essential for the success of this initiative. Factors, such as security and privacy fears, issues over the accuracy and quality of patient data, prices, time limits, lack of awareness and legal uncertainty may be responsible for suppliers’ reluctance to implement mobile CDSS.
Global Clinical Decision Support System Market: Region
North America to grow at the highest CAGR during the forecast period
Global Clinical Decision Support System market is segmented on the basis of regional analysis into five major regions. These include North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. Geographically, North America is likely to dominate the market due to high adoption rate of cloud technology in the healthcare sector. In addition, the rise in investment in mobile and emerging technology in the health sector is expected to boost the overall market growth during the forecast period. Additionally, the clinical decision support system market is likely to grow in the Asia-Pacific region due to growing popularity and increasing health expenditure in regions such as India, China and Japan.

Key Players
· Wolters Kluwer Health
Company overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
· Hearst Health
· Elsevier B.V.
· McKesson Corporation
· Cerner Corporation
· Epic Systems Corporation
· MEDITECH
· Philips Healthcare
· IBM
· Allscripts Healthcare Solutions

Global Clinical Decision Support System Market Report also contains an analysis on:
· Clinical Decision Support System Market by segment:
• By Type
Therapeutic
Diagnostic

• By Component
Software
Hardware
Services

• By Mode of Delivery
On-Premise
Cloud

• By Product Outlook
Standalone
Integrated

• By Application
Drug Interactions
Drug Allergy Alerts
Clinical Reminders
Clinical Guidelines
Drug Dosing Support
Others

• By Region
North America
Latin America
Europe
Asia-Pacific
Middle east and Africa

· Clinical Decision Support System Market Size
· Clinical Decision Support System Market Dynamics
· Supply and Demand
· Current Issues/trends/challenges
· Competition and Companies Involved in the Market
· Value Chain of the Market
· Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. Clinical Decision Support System
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Recent Development, Policies & Regulatory Landscape
7. Risk Analysis
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. Clinical Decision Support System Industry Analysis
8.1. Porters Five Forces
8.1.1. Threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. Global Clinical Decision Support System Market
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. Global Clinical Decision Support System: Market Segmentation
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Type: Market Share (2020-2030F)
10.2.1. Therapeutic, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Diagnostic, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By Component: Market Share (2020-2030F)
10.3.1. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Hardware, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4. By Mode of Delivery: Market Share (2020-2030F)
10.4.1. On-Premise, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.2. Cloud, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5. By Product Outlook: Market Share (2020-2030F)
10.5.1. Standalone, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5.2. Integrated, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6. By Applications: Market Share (2020-2030F)
10.6.1. Drug Interactions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.2. Drug Allergy Alerts, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.3. Clinical Reminders, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.4. Clinical Guidelines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.5. Drug Dose Support, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. Company Profile
11.1. Wolters Kluwer Health
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Hearst Health
11.3. Elsevier B.V.
11.4. McKesson Corporation
11.5. Cerner Corporation
11.6. Epic Systems Corporation
11.7. MEDITECH
11.8. Philips Healthcare
11.9. IBM
11.10. Allscripts Healthcare Solutions
12. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.